• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Neurotrope forms Clinical Advisory Board to support Alzheimer's disease program

Neurotrope forms Clinical Advisory Board to support Alzheimer's disease program

January 16, 2015
CenterWatch Staff

Neurotrope has formed its Alzheimer's Disease Clinical Advisory Board (CAB) with the following appointments: Jeffery L. Cummings, M.D., ScD, CCF; Martin R. Farlow, M.D.; Sam Gandy, M.D., Ph.D.; Christina Sampaio, M.D., Ph.D.; and Michael Weiner, M.D.

Charles S. Ramat, president and CEO of Neurotrope, said, "With our company having recently completed dosing patients in our phase IIa bryostatin study for the treatment of Alzheimer's disease, the appointment of our CAB members comes at a pivotal time for Neurotrope. We look forward to the release of data from that study early in 2015 and the assistance from our new CAB members in helping us further the clinical development and eventual commercialization of this important potential treatment for Alzheimer's disease."

Cummings, chairman, is director of Cleveland Clinic Lou Ruvo Center for Brain Health; director of Materials Science and Engineering Center for Alzheimer's Disease Research; and director of the Deane F. Johnson Center for Neurotherapeutics at UCLA.

Farlow is professor and vice chairman of research, dept. of neurology, at Indiana University; associate co-director of the Indiana Alzheimer's Disease Center; and member of the government Alzheimer's task force.

Gandy works at Mount Sinai. Gandy is chair in Alzheimer's research and is a professor of neurology and psychiatry at Mount Sinai. Gandy was director of the Mount Sinai Center for Cognitive Health and NFL Neurological Care, is a former chairman of the National Medical and Scientific Advisory Council of the Alzheimer's Association and is founding director of the Farber Institute of Neurosciences, Jefferson Medical College.

Sampaio is chief medical officer at the Cure Huntington's Disease Initiative Foundation; professor of clinical pharmacology and therapeutics at the University of Lisbon, Portugal; and former member of the Committee of Proprietary Medicinal Products and the Scientific Advice Working Party at the EMA.

Weiner is a professor at UCSF School of Medicine in radiology and biomedical imaging and Principal Investigator of the Alzheimer's Disease Neuroimaging Initiative

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Virtual Doctoer

    Simple Changes Can Make Trials More Patient Friendly

  • Drug approval

    Two-Thirds of Trial Subjects for Drug Approvals Are Outside the U.S.

  • VaccinewithNeedle-360x240.png

    Rules of Vaccine Approval May Be Changing, But Statistical Analysis Tools Remain Constant

  • AskTheExperts-360x240.png

    Ask the Experts: Trial Operations Adjustments in a Remote World

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing